At the news
? NEUTRALIMPACT 4/10 PRESS-RELEASE filed Mar 31, 2026 at 07:49 ET
WW International announced an expanded collaboration with Novo Nordisk to offer eligible Med+ members discounted subscription pricing for Wegovy, saving up to $1,200 annually. This enhances access to GLP-1 treatment and reinforces WW's integrated weight health model, though no financial impact on revenue or profitability was quantified.
- WW International and Novo Nordisk expanded their collaboration to offer subscription pricing for Wegovy to eligible Med+ members.
- Members can save up to $1,200 per year, or up to $100/month on pens and $50/month on pills, via pre-paid 3, 6, or 12-month plans.
- The offer applies to all Wegovy pen doses and 9 mg/25 mg pill doses; existing limited-time offers also remain available.
- WW is a NovoCare® Recognized Care Provider and emphasizes combining medication with lifestyle support for better outcomes.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access